- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 128,193,288
- Share change
- -499,148
- Total reported value
- $29,710,612,652
- Put/Call ratio
- 119%
- Price per share
- $231.82
- Number of holders
- 933
- Value change
- -$84,741,446
- Number of buys
- 399
- Number of sells
- 429
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
16,570,398
|
$3,573,074,920 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
16,220,716
|
$3,497,672,991 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.6%
|
14,144,988
|
$3,050,083,805 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
6,747,008
|
$1,454,857,335 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.5%
|
5,169,970
|
$1,114,801,000 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.5%
|
5,120,142
|
$1,104,056,220 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.2%
|
4,720,144
|
$1,017,804,663 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
3,409,674
|
$733,409,434 | — | 31 Mar 2024 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
1.2%
|
1,737,340
|
$374,623,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,701,383
|
$366,869,843 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,668,017
|
$359,674,505 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
1,589,629
|
$342,772,000 | — | 31 Mar 2024 | |
| Beutel, Goodman & Co Ltd. |
13F
|
Company |
1.1%
|
1,565,785
|
$337,630,000 | — | 31 Mar 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.1%
|
1,561,660
|
$336,740,638 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1%
|
1,523,141
|
$328,434,894 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
1,388,386
|
$299,377,674 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.94%
|
1,376,002
|
$296,707,289 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.9%
|
1,320,986
|
$284,844,150 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.89%
|
1,307,720
|
$281,983,668 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
1,057,461
|
$228,020,315 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.69%
|
1,014,278
|
$218,922,210 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
994,365
|
$214,414,789 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.66%
|
972,143
|
$209,623,196 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.61%
|
900,900
|
$194,261,067 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.6%
|
884,704
|
$190,769,000 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.67%
|
985,802
|
$187,814,997 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
858,805
|
$185,184,182 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.57%
|
842,467
|
$181,661,159 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.54%
|
798,660
|
$172,300,086 | — | 31 Mar 2024 | |
| Alexander J. Denner |
3/4/5
|
Director |
—
class O/S missing
|
658,099
|
$163,208,552 | — | 15 Jun 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.5%
|
740,727
|
$159,722,963 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
0.48%
|
702,412
|
$151,461,099 | — | 31 Mar 2024 | |
| Employees Provident Fund Board |
13F
|
Company |
0.46%
|
678,080
|
$146,214,390 | — | 31 Mar 2024 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.44%
|
643,000
|
$138,650,090 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.42%
|
620,850
|
$133,873,713 | — | 31 Mar 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.42%
|
620,244
|
$133,743,213 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.39%
|
574,975
|
$123,981,859 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.39%
|
570,533
|
$123,024,000 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.37%
|
540,565
|
$116,562,030 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
475,826
|
$102,602,362 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.31%
|
455,864
|
$98,297,954 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
443,622
|
$95,658,103 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.3%
|
433,900
|
$93,561,857 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.28%
|
407,838
|
$87,942,108 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.27%
|
404,419
|
$87,204,869 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.27%
|
403,278
|
$86,959,000 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
0.27%
|
400,000
|
$86,252,000 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.27%
|
398,842
|
$85,983,429 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
386,482
|
$83,337,114 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.26%
|
385,583
|
$83,143,263 | — | 31 Mar 2024 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q2 2024
As of 30 Jun 2024,
BIOGEN INC. - Common Stock (BIIB) was held by
933 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,193,288 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., STATE STREET CORP, T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, NORGES BANK, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
937
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
932
Q2 2024 holders
933
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.